Mayne Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?
MAYNE PHARMA INC has two approved drugs.
There is one tentative approval on MAYNE PHARMA INC drugs.
Summary for Mayne Pharma Inc
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Mayne Pharma Inc: | See patent lawsuits for Mayne Pharma Inc |
Drugs and US Patents for Mayne Pharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma Inc | HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205658-001 | Nov 17, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Mayne Pharma Inc | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205657-001 | Aug 3, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.